MITIGAAT: Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants
Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT)
Medical University of South Carolina
190 participants
Feb 27, 2024
INTERVENTIONAL
Conditions
Summary
This is a randomized study to test a smartphone app that a pharmacist will use to help kidney transplant patients track their medications, blood pressures, and blood sugars in those with diabetes. The goal of this study is to improve care and outcomes in kidney transplant patients and, in particular, help African American patients have better outcomes after transplant.
Eligibility
Inclusion Criteria2
- ≥18 years of age
- ≥2 years post-kidney transplant
Exclusion Criteria4
- Non-kidney transplant recipient (liver, lung, heart, intestine, pancreas, bone marrow)
- Not capable of measuring own BP and glucose in those with diabetes
- Not capable of using mobile health application after adequate training
- Not capable of speaking, hearing, and reading English
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In the interventional group, the subject would receive the standard care that is provided to all post-transplant kidney recipients plus an additional remote monitoring system and follow-up by utilizing an app known as the mHealth app/dashboard. This app is integrated with home-based monitoring of blood pressures, glucoses, and pharmacist-led scheduled televisits.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06023615